[ Price : $8.95]
FDA warns South Koreas Daewoo Pharmaceutical Co. about CGMP violations in its production of finished drugs.[ Price : $8.95]
A Benefits Pensions Monitor report says FDA drug inspection backlogs can hurt Canada since FDA has been performing 70% of Canadas ...[ Price : $8.95]
FDA reviewers plan to ask an advisory committee this week about its concerns with ocular toxicity seen in trial data submitted by ...[ Price : $8.95]
FDA warns Dr. Mark Savant and his San Francisco Research Institute about bioresearch monitoring violations in his conduct of a cli...[ Price : $8.95]
FDA approves a Biocon Biologics BLA for its rapid-acting interchangeable biosimilar insulin product Kirsty (insulin aspart-xjhz).[ Price : $8.95]
FDA releases the form FDA-483 containing eight observations from an inspection at the Sun Pharmaceutical drug manufacturing facili...[ Price : $8.95]
Researchers, including CBER director Vinay Prasad, call for incentivized or mandated head-to-head randomized controlled trials of ...[ Price : $8.95]
BD and subsidiary CareFusion issue an Urgent Medical Device Recall (Correction) letter related to performance issues involving the...